Search Results 451-460 of 1455 for 牛客网的ai面试,ai少女官网下载,法律ai网站,在线ai绘画网站,ai语音合成网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Mooney Mori, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Mooney Mori, M.D., Ph.D., is a physician-scientist at Mayo Clinic specializing in organ generative medicine and end-stage lung disease treatments.

  2. Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    The purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of ...

  4. Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

    About this study. The Valchlor PROVe study is a multi-center, prospective, observational, US-based drug study that longitudinally follows patients with ...

  5. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency - Mayo Clinic

    The purpose of this study (Study INZ701-304 [ADAPT])) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ...

  6. Faculty - Women's Health Research Center - Mayo Clinic Research

    Torgerson, Rochelle R. M.D., Ph.D. Associate Professor of Dermatology. Trabuco, Emanuel C. M.D. · trabuco.emanuel@mayo.edu; Professor of Obstetrics and ...

  7. Evaluation of Radiculitis Following Use of Bone Morphogenetic Protein-2 for Interbody Arthrodesis in Spinal Surgery - Mayo Clinic

    What is the incidence and etiology of bone overgrowth in protein versus other bone graft? Participation eligibility. Participant eligibility includes age, ...

  8. Hancheng Cai, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Hancheng Cai, PhD, is a radiochemist and molecular imaging scientist. My clinical work focus on FDA cGMP PET drug production facility implementation and ...

  9. Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis - Mayo Clinic

    The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in adults with primary biliary cholangitis (PBC). Participation ...

  10. Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients - Mayo Clinic

    To determine the effects of 12 weeks administration of different dose levels of ALV003 on the mucosal lining of the small intestine and symptoms in celiac ...